Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Proteome Res
2011 Jun 03;106:2842-51. doi: 10.1021/pr200093w.
Show Gene links
Show Anatomy links
Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1).
Wikoff WR
,
Nagle MA
,
Kouznetsova VL
,
Tsigelny IF
,
Nigam SK
.
???displayArticle.abstract???
Untargeted metabolomics on the plasma and urine from wild-type and organic anion transporter-1 (Oat1/Slc22a6) knockout mice identified a number of physiologically important metabolites, including several not previously linked to Oat1-mediated transport. Several, such as indoxyl sulfate, derive from Phase II metabolism of enteric gut precursors and accumulate in chronic kidney disease (CKD). Other compounds included vitamins (pantothenic acid, 4-pyridoxic acid), urate, and metabolites in the tryptophan and nucleoside pathways. Three metabolites, indoxyl sulfate, kynurenine, and xanthurenic acid, were elevated in the plasma and interacted strongly and directly with Oat1 in vitro with IC50 of 18, 12, and 50 μM, respectively. A pharmacophore model based on several identified Oat1 substrates was used to screen the NCI database and candidate compounds interacting with Oat1 were validated in an in vitro assay. Together, the data suggest a complex, previously unidentified remote communication between the gut microbiome, Phase II metabolism in the liver, and elimination via Oats of the kidney, as well as indicating the importance of Oat1 in the handling of endogenous toxins associated with renal failure and uremia. The possibility that some of the compounds identified may be part of a larger remote sensing and signaling pathway is also discussed.
???displayArticle.pubmedLink???
21476605
???displayArticle.pmcLink???PMC3201759 ???displayArticle.link???J Proteome Res ???displayArticle.grants???[+]
Ahn,
Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis.
2009, Pubmed
Ahn,
Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis.
2009,
Pubmed
Ahn,
Interaction of organic cations with organic anion transporters.
2009,
Pubmed
,
Xenbase
Bahn,
Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites.
2005,
Pubmed
Beger,
Metabonomics of acute kidney injury in children after cardiac surgery.
2008,
Pubmed
Benton,
XCMS2: processing tandem mass spectrometry data for metabolite identification and structural characterization.
2008,
Pubmed
Brandoni,
Renal elimination of p-aminohippurate (PAH) in response to three days of biliary obstruction in the rat. The role of OAT1 and OAT3.
2006,
Pubmed
Deguchi,
Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in vivo renal uptake of uremic toxins in rats.
2005,
Pubmed
Dou,
The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair.
2004,
Pubmed
Dresser,
Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters.
2001,
Pubmed
Eraly,
Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice.
2006,
Pubmed
,
Xenbase
Eraly,
Novel slc22 transporter homologs in fly, worm, and human clarify the phylogeny of organic anion and cation transporters.
2004,
Pubmed
Ertl,
Molecular structure input on the web.
2010,
Pubmed
Fahy,
LIPID MAPS online tools for lipid research.
2007,
Pubmed
Feldmesser,
Widespread ectopic expression of olfactory receptor genes.
2006,
Pubmed
Hwang,
Metabolic profiling of kidney and urine in rats with lithium-induced nephrogenic diabetes insipidus by (1)H-NMR-based metabonomics.
2010,
Pubmed
Kaler,
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
2007,
Pubmed
Kikuchi,
Metabolomic analysis of uremic toxins by liquid chromatography/electrospray ionization-tandem mass spectrometry.
2010,
Pubmed
Lampe,
The Human Microbiome Project: getting to the guts of the matter in cancer epidemiology.
2008,
Pubmed
Lenz,
Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat.
2005,
Pubmed
Lopez-Nieto,
Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney.
1997,
Pubmed
,
Xenbase
Mai,
Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health.
2009,
Pubmed
Motojima,
Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake.
2002,
Pubmed
Nigam,
Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues.
2007,
Pubmed
,
Xenbase
Ogata,
KEGG: Kyoto Encyclopedia of Genes and Genomes.
1999,
Pubmed
Peterson,
The NIH Human Microbiome Project.
2009,
Pubmed
Petrosino,
Metagenomic pyrosequencing and microbial identification.
2009,
Pubmed
Proal,
Autoimmune disease in the era of the metagenome.
2009,
Pubmed
Rhee,
Metabolite profiling identifies markers of uremia.
2010,
Pubmed
Schüttelkopf,
PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.
2004,
Pubmed
Smith,
METLIN: a metabolite mass spectral database.
2005,
Pubmed
Sweet,
Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models.
2006,
Pubmed
Taylor,
A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease.
2010,
Pubmed
Tetko,
Internet software for the calculation of the lipophilicity and aqueous solubility of chemical compounds.
2001,
Pubmed
Truong,
Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination.
2008,
Pubmed
,
Xenbase
Turnbaugh,
The core gut microbiome, energy balance and obesity.
2009,
Pubmed
Turnbaugh,
The human microbiome project.
2007,
Pubmed
VanWert,
Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology.
2010,
Pubmed
Weltman,
The HF-SCF energy of HIV-1 MNgp120 V3 hairpin loop conformers.
2004,
Pubmed
Wikoff,
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites.
2009,
Pubmed
Williams,
D-Serine-induced nephrotoxicity: a HPLC-TOF/MS-based metabonomics approach.
2005,
Pubmed
Wishart,
HMDB: the Human Metabolome Database.
2007,
Pubmed
Wu,
Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis.
2011,
Pubmed
Wu,
Analysis of a large cluster of SLC22 transporter genes, including novel USTs, reveals species-specific amplification of subsets of family members.
2009,
Pubmed
Zaïr,
Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney.
2008,
Pubmed
Zhang,
Genomics of olfactory receptors.
2009,
Pubmed
Zhang,
High-throughput microarray detection of olfactory receptor gene expression in the mouse.
2004,
Pubmed
van Aalten,
PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules.
1996,
Pubmed
van de Wetering,
Targeted metabolomics identifies glucuronides of dietary phytoestrogens as a major class of MRP3 substrates in vivo.
2009,
Pubmed
